Deep brain stimulation (dbs): treatment for patients with a diagnosis of resistant obsessive-compulsive disorder
Article Sidebar
Main Article Content
Abstract
Obsessive-compulsive disorder (OCD) affects 2% of the general population, sometimes resulting in severe impairment of functional capacity and quality of life of affected people. Between 10 and 30% of these patients do not respond to recommended treatments: pharmacological and cognitive behavioral therapy. In 2008, the FDA approved Deep Brain Stimulation (DBS) for patients with OCD resistant to treatment. DBS, frequently used for the treatment of refractory Parkinson’s disease, is a viable option for the treatment of patients with resistant OCD, with infrequent and transient adverse effects.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
References
Ruscio AM, Stein DJ, Chiu WT, et al. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatr. 2010; 15(1):53.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5®. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
Saleh C, Fontaine D. Deep brain stimulation for psychiatric diseases: what are the risks? Curr Psychiat Rep. 2015; 17(5):33.
Greenberg BD, RauchSL, Haber SN. Invasive circuitry-based neurotherapeutics: stereotactic ablation and deep brain stimulation for OCD. Neuropsychopharmacology. 2010; 35(1):317-36.
US Food and Drug Administration. FDA News Release: FDA Approves Humanitarian Device Exemption for Deep Brain Stimulator for Severe Obsessive-Compulsive Disorder. February 19, 2009.
Yampolsky C, Bendersky D. Cirugía de los trastornos del comportamiento: el estado del arte. Surg Neurol Int. 2014; 5:S211-31.
Höflich A, SavliM, ComascoE, et al. Neuropsychiatric deep brain stimulation for translational neuroimaging. NeuroImage. 2013; 79:30-41.
Holtzheimer PE, Mayberg HS. Deep brain stimulation for psychiatric disorders. Annu Rev Neurosci. 2011; 34:289-307.
Van Westen M, Rietveld E, Figee M, et al. Clinical outcome and mechanisms of deep brain stimulation for obsessive-compulsive disorder. Curr Behav Neurosci Rep.2015; 2(2):41-8.
de Koning PP, Figee M, van den Munckhof P, et al. Current status of deep brain stimulation for obsessive-compulsive disorder: a clinical review of different targets. Curr Psychiat Rep. 2011; 13(4):274-82.
Blomstedt P, Sjöberg RL, Hansson M, et al. Deep brain Stimulation in the treatment of obsessive-compulsive disorder. World Neurosurg. 2013; 80(6):e245-53.
Alonso P, Cuadras D, Gabriëls L, et al. Deep brain stimulation for obsessive-compulsive disorder: a meta-analysis of treatment outcome and predictors of response. PloS One. 2015; 10(7):e0133591.
Fayad S M, Guzick A G, Reid AM, et al. Six-nine-year follow-up of deep brain stimulation for obsessive-compulsive disorder. PloS One. 2016; 11(12): e0167875.
Raymaekers S, Vansteelandt K, Luyten L, et al. Long-term electrical stimulation of bed nucleus of stria terminalis for obsessive-compulsive disorder. Mol Psychiatr. 2017; 22(6):931.
Bergfeld IO, Mantione M, Hoogendoorn ML, et al. Cognitive functioning in psychiatric disorders following deep brain stimulation. Brain Stimul. 2013; 6(4):532-7.